Functional Expression of Carnitine/Organic Cation Transporter 1 in Murine Choroid Plexus

被引:0
|
作者
Ishimoto, Takahiro [1 ]
Nakamichi, Noritaka [1 ,2 ]
Taguchi, Takayuki [1 ]
Nishiyama, Misa [1 ]
Kato, Yukio [1 ]
机构
[1] Kanazawa Univ, Fac Pharm, Kanazawa, Ishikawa 9201192, Japan
[2] Takasaki Univ Hlth & Welf, Fac Pharm, 60 Nakaorui Machi, Takasaki, Gunma 3700033, Japan
关键词
organic cation transporter 1; choroid plexus; blood-cerebrospinal fluid barrier; ergothioneine; MOUSE-BRAIN; KNOCKOUT; MICE;
D O I
10.1248/bpb.b24-00451
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Membrane transporters expressed in the choroid plexus (CP) are involved in the transport of substances between the blood and cerebrospinal fluid (CSF). Carnitine/organic cation transporter 1 (OCTN1, also known as SLC22A4) is expressed in rodent CP; however, its specific roles in blood-CSF transport remain unclear. Therefore, in this study, we aimed to evaluate the potential role of OCTN1 in the elimination of substances from CSF. Tritium-labeled ergothioneine ([H-3]ERGO), a typical in vivo substrate of OCTN1, was injected into the lateral ventricles of wild- type and octn1 gene knockout (octn1(-/-)) mice. Clearance of [H-3] ERGO from CSF was higher than that of the bulk flow marker, [C-14]mannitol, in wild-type mice. However, [H-3]ERGO clearance was significantly lower in octn1(-/-) mice than in wild-type mice. Furthermore, OCTN1 expression in CP was determined via immunohistochemical analysis. CP/CSF ratio of [H-3]ERGO was significantly lower in octn1(-/-) mice than in wild-type mice. These results suggest that OCTN1 is functionally expressed in CP and involved in the elimination of ERGO from CSF in mice.
引用
收藏
页码:1484 / 1486
页数:3
相关论文
共 50 条
  • [41] Regulation Mechanisms of Expression and Function of Organic Cation Transporter 1
    Ciarimboli, Giuliano
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [42] Functional analysis of carnitine/organic cation transporter OCTN1 (SLC22A4) expressed in mouse brain
    Nakamichi, Noritaka
    Taguchi, Takayuki
    Hosotani, Hiroshi
    Yamada, Hiroya
    Sugiura, Tomoko
    Kato, Yukio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 119P - 119P
  • [43] Functional characterization of ergothioneine transport by rat organic cation/carnitine transporter OCTN1 (slc22a4)
    Nakamura, Toshimichi
    Yoshida, Kenji
    Yabuuchi, Hikaru
    Maeda, Tomoji
    Tamai, Ikumi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (08) : 1580 - 1584
  • [44] Functional expression of human organic cation transporter 3 in renal cancer cells
    Shnitsar, Volodymyr
    Koepsell, Hermann
    Burckhardt, Gerhard
    Hagos, Yohannes
    FASEB JOURNAL, 2008, 22
  • [45] ORGANIC CATION TRANSPORTER 1 (OCT1) EFFLUXES CARNITINE AND ACYLCARNITINES FROM THE LIVER TO BLOOD
    Kim, Hye In
    Lu, Wenyun
    Bennett, Michael
    Rabinowitz, Joshua
    Hand, Nicholas
    Rader, Daniel
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) : 264 - 265
  • [46] Organic cation transport in rat choroid plexus cells studied by fluorescence microscopy
    Miller, DS
    Villalobos, AR
    Pritchard, JB
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (04): : C955 - C968
  • [47] Apical organic cation transport by primary cultures of rat choroid plexus.
    Villalobos, AR
    Miller, DS
    Pritchard, JB
    FASEB JOURNAL, 1996, 10 (03): : 730 - 730
  • [48] Functional expression of a high affinity mammalian hepatic choline/organic cation transporter
    Sinclair, CJ
    Chi, KD
    Subramanian, V
    Ward, KL
    Green, RM
    JOURNAL OF LIPID RESEARCH, 2000, 41 (11) : 1841 - 1848
  • [49] Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells
    Elimrani, I
    Lahjouji, K
    Seidman, E
    Roy, MJ
    Mitchell, GA
    Qureshi, I
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 284 (05): : G863 - G871
  • [50] Effect of Red Wine Polyphenols on the Expression of Transthyretin in Murine Choroid Plexus
    Tenore, Gian C.
    Morisco, Filomena
    Lembo, Vincenzo
    Ritieni, Alberto
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2016, 17 (11) : 1008 - 1015